Shinya Kohno

Title: Shinya Kohno: Innovator in T Cell Modification

Introduction

Shinya Kohno is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of immunology, particularly in the modification of T cell populations. His innovative work has implications for cancer treatment and infectious diseases.

Latest Patents

Shinya Kohno holds a patent for a method aimed at modifying T cell populations. This patent includes a compound represented by formula (I) and outlines a retinoid metabolic pathway inhibitor. The invention also describes an agent for increasing the ratio of memory T cells, which can serve as a prophylactic and/or therapeutic agent for cancer or infectious diseases. Additionally, it includes a cancer immunotherapeutic adjuvant and an immunopotentiator, along with a method for preparing a T cell population that increases the ratio of memory T cells using the compound of formula (I). He has 1 patent to his name.

Career Highlights

Throughout his career, Shinya Kohno has worked with esteemed institutions such as Osaka University and Knc Laboratories Co., Ltd. His research has focused on enhancing the efficacy of T cell therapies, which are crucial in modern immunotherapy.

Collaborations

Shinya Kohno has collaborated with notable colleagues, including Haruo Sugiyama and Fumihiro Fujiki. Their joint efforts have contributed to advancements in the understanding and application of T cell modifications.

Conclusion

Shinya Kohno's innovative work in T cell modification represents a significant advancement in immunotherapy. His contributions have the potential to improve treatment outcomes for patients with cancer and infectious diseases.